• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13D/A filed by Enovix Corporation

    7/22/25 4:41:39 PM ET
    $ENVX
    Industrial Machinery/Components
    Miscellaneous
    Get the next $ENVX alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 3)


    ENOVIX CORPORATION

    (Name of Issuer)


    Common Stock, $0.0001 par value per share

    (Title of Class of Securities)


    293594107

    (CUSIP Number)


    Thurman J. Rodgers
    535 Eastview Way,
    Woodside, CA, 94062
    (510) 695-2350


    Arthi Chakravarthy
    3501 W. Warren Avenue,
    Fremont, CA, 94538
    (510) 695-2350

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
    07/17/2025

    (Date of Event Which Requires Filing of This Statement)


    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






    SCHEDULE 13D

    CUSIP No.
    293594107


    1 Name of reporting person

    Thurman J. Rodgers
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    OO
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    28,998,622.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    28,998,622.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    28,998,622.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    14.4 %
    14Type of Reporting Person (See Instructions)

    IN

    Comment for Type of Reporting Person:
    Rows 7, 9 and 11: Consists of (i) 5,635 shares of common stock, par value $0.0001 per share ("Common Stock"), of Enovix Corporation, a Delaware corporation (the "Issuer"), issuable upon the settlement of restricted stock units ("RSUs") within 60 days of July 17, 2025 that are held directly by Thurman J. Rodgers ("Mr. Rodgers"), (ii) 20,801,265 shares of Common Stock held by the Rodgers Massey Revocable Living Trust dtd 4/4/11 (the "Living Trust"), of which Mr. Rodgers is a trustee, (iii) 2,971,609 shares of Common Stock issuable to the Living Trust pursuant to warrants exercisable within 60 days of July 21, 2025, (iv) 4,100,000 shares of Common Stock issuable to the Living Trust pursuant to a warrant exercisable within 60 days of December 31, 2022, and (v) 900,000 shares of Common Stock held by the Rodgers Family Freedom and Free Markets Charitable Trust, of which Mr. Rodgers is a trustee (the "Charitable Trust"), and (vi) 220,113 shares of Common Stock issuable to the Charitable Trust pursuant to warrants exercisable within 60 days of July 21, 2025. Mr. Rodgers has sole power to vote or direct the vote, and dispose or direct the disposition of, all of the shares of Common Stock that he beneficially holds, except that with respect to shares held by the Living Trust and Charitable Trust, voting and dispositive power is shared by Mr. Rodgers and his spouse. The percentages used in row 13 of this Amendment No. 3 are calculated based upon 193,579,119 shares of Common Stock outstanding as of July 17, 2025 as reported in the Prospectus Supplement filed by the Issuer with the SEC on July 21, 2025.


    SCHEDULE 13D

    CUSIP No.
    293594107


    1 Name of reporting person

    Rodgers Massey Revocable Living Trust dtd 4/4/11
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    OO
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    27,872,874.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    27,872,874.00
    11Aggregate amount beneficially owned by each reporting person

    27,872,874.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    13.9 %
    14Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:
    Rows 8, 10 and 11: Includes (i) 4,100,000 shares of Common Stock issuable to the Living Trust pursuant to a warrant exercisable within 60 days of December 31, 2022, and (ii) 2,971,609 shares of Common Stock issuable to the Living Trust pursuant to warrants exercisable within 60 days of July 21, 2025. The percentages used in row 13 of this Amendment No. 3 are calculated based upon 193,579,119 shares of Common Stock outstanding as of July 17, 2025 as reported in the Prospectus Supplement filed by the Issuer with the SEC on July 21, 2025.


    SCHEDULE 13D

    CUSIP No.
    293594107


    1 Name of reporting person

    Rodgers Family Freedom and Free Markets Charitable Trust
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    OO
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    1,120,113.00
    8Shared Voting Power

    0.00
    9Sole Dispositive Power

    1,120,113.00
    10Shared Dispositive Power

    0.00
    11Aggregate amount beneficially owned by each reporting person

    1,120,113.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    0.1 %
    14Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:
    Rows 7, 9 and 11: Includes 220,113 shares of Common Stock issuable to the Charitable Trust pursuant to warrants exercisable within 60 days of July 21, 2025. The percentages used in row 13 of this Amendment No. 3 are calculated based upon 193,579,119 shares of Common Stock outstanding as of July 17, 2025 as reported in the Prospectus Supplement filed by the Issuer with the SEC on July 21, 2025.


    SCHEDULE 13D

    Item 1.Security and Issuer
    (a)Title of Class of Securities:

    Common Stock, $0.0001 par value per share
    (b)Name of Issuer:

    ENOVIX CORPORATION
    (c)Address of Issuer's Principal Executive Offices:

    3501 W Warren Avenue, Fremont, CALIFORNIA , 94538.
    Item 1 Comment:
    This Amendment No. 3 is being filed as an amendment to the statement on Schedule 13D relating to the Common Stock, filed with the SEC on July 26, 2021, as amended on September 10, 2021 and February 14, 2023. Unless otherwise defined herein, capitalized terms used in this Amendment No. 3 shall have the meanings ascribed to them in the Statement. Unless amended or supplemented below, the information in the Statement remains unchanged.
    Item 3.Source and Amount of Funds or Other Consideration
     
    Item 3 is hereby supplemented by adding the following: On March 10, 2023 the Charitable Trust purchased 65,134 shares of Common Stock at a weighted-average price of $9.56 per share, as previously reported on a Form 4 filed with the SEC on March 10, 2023. On March 15, 2023 the Charitable Trust purchased 129,111 shares of Common Stock at a weighted-average price of $10.47 per share, as previously reported on a Form 4 filed with the SEC on March 15, 2023. On March 16, 2023 the Charitable Trust purchased 34,899 shares of Common Stock at a weighted-average price of $10.96 per share, as previously reported on a Form 4 filed with the SEC on March 16, 2023. On March 17, 2023 the Charitable Trust purchased 98,700 shares of Common Stock at a weighted-average price of $10.95 per share, as previously reported on a Form 4 filed with the SEC on March 17, 2023. On March 20, 2023 the Charitable Trust purchased 69,557 shares of Common Stock at a weighted-average price of $10.88 per share, as previously reported on a Form 4 filed with the SEC on March 20, 2023. On March 21, 2023 the Charitable Trust purchased 102,599 shares of Common Stock at a weighted-average price of $11.57 per share, as previously reported on a Form 4 filed with the SEC on March 21, 2023. On March 24, 2023, Mr. Rodgers transferred 2,264 shares of Common Stock to the Living Trust for no consideration, as previously reported on a Form 4 filed with the SEC on March 27, 2023. Pursuant to a subscription agreement, entered into on April 17, 2023, the Issuer issued and sold $10.0 million aggregate principal amount of 3.00% Convertible Senior Notes due 2028 ("Convertible Senior Notes") to the Charitable Trust. The Notes are convertible at the option of the Holder into cash, shares of the Common Stock, or a combination of cash and shares of Common Stock, at the Issuer's election, subject to certain adjustments. The Convertible Senior Notes are initially convertible into shares of Common Stock at an initial conversion rate of 64.0800 shares of Common Stock per $1,000 principal amount of Senior Convertible Notes, which is subject to customary anti-dilution adjustment provisions. The Convertible Senior Notes are not convertible within 60 days of July 17, 2025 absent the occurrence of certain conditions relating to the Issuer's stock price. Between May 16-17, 2023, the Living Trust gifted for no consideration an aggregate of 8,000 shares of Common Stock, as previously reported on a Form 4 filed with the SEC on May 17, 2023. On June 5, 2023, the Living Trust gifted for no consideration an aggregate of 2,000 shares of Common Stock, as previously reported on a Form 4 filed with the SEC on June 5, 2023. On June 15, 2023, Mr. Rodgers received 7,336 shares of Common Stock in connection with the settlement of RSUs granted pursuant to the 2021 Plan, as previously reported on a Form 4 filed with the SEC on June 20, 2023. On June 20, 2023, the Living Trust gifted for no consideration an aggregate of 50,000 shares of Common Stock, as previously reported on a Form 4 filed with the SEC on June 22, 2023. On December 22, 2023, the Living Trust donated 36,025 shares of the Common Stock as a charitable contribution to a charitable gift fund for no consideration, as previously reported on a Form 4 filed with the SEC on December 27, 2023. On January 3, 2024, Mr. Rodgers transferred 3,668 shares of Common Stock to the Living Trust for no consideration, as previously reported on a Form 4 filed with the SEC on March 24, 2024. On March 21, 2024, Mr. Rodgers transferred 1,834 shares of Common Stock to the Living Trust for no consideration, as previously reported on a Form 4 filed with the SEC on March 24, 2024. On June 13, 2024, Mr. Rodgers received 15,128 RSUs pursuant to the 2021 Plan, as previously reported on a Form 4 filed with the SEC on June 17, 2024. On June 21, 2024, Mr. Rodgers transferred 1,834 shares of Common Stock to the Living Trust for no consideration, as previously reported on a Form 4 filed with the SEC on June 24, 2024. On September 26, 2024, Mr. Rodgers transferred 3,782 shares of Common Stock to the Living Trust for no consideration, as previously reported on a Form 4 filed with the SEC on September 30, 2024. On December 30, 2024, Mr. Rodgers transferred 3,782 shares of Common Stock to the Living Trust for no consideration, as previously reported on a Form 4 filed with the SEC on December 31, 2024. On April 1, 2025, Mr. Rodgers transferred 3,782 shares of Common Stock to the Living Trust for no consideration, as previously reported on a Form 4 filed with the SEC on April 3, 2025. On June 12, 2024, Mr. Rodgers received 22,543 RSUs pursuant to the 2021 Plan, as previously reported on a Form 4 filed with the SEC on June 13, 2025. On June 16, 2025, Mr. Rodgers transferred 3,782 shares of Common Stock to the Living Trust for no consideration, as previously reported on a Form 4 filed with the SEC on June 17, 2025. On July 21, 2025, the Issuer distributed warrants to purchase Common Stock (the "Dividend Warrants") to the record holders as of July 17, 2025 (the "Record Date") of the Common Stock, at a rate of one Dividend Warrant for each seven shares of Common Stock (rounded down to the nearest whole number), and each holder of the Convertible Senior Notes as of the Record Date at a rate equal to the product of (i) the conversion rate applicable to the Convertible Senior Notes in effect on the Record Date and (ii) the aggregate principal amount (expressed in thousands) of Convertible Senior Notes held by such holder on such date (the "Warrant Distribution"). As a result of the Warrant Distribution, the Living Trust received Dividend Warrants to purchase 2,971,661 shares of Common Stock and the Charitable Trust received Dividend Warrants to purchase 220,113 shares of Common Stock. The Dividend Warrants are exercisable within 60 days of July 21, 2025.
    Item 4.Purpose of Transaction
     
    Reflects the aggregate number of warrants to purchase Common Stock distributed on July 21, 2025 to the Issuer's record holders as of July 17, 2025.
    Item 5.Interest in Securities of the Issuer
    (a)
    See rows (11) and (13) of the cover pages to this Amendment No. 3 for the aggregate number of shares and percentages of the shares beneficially owned by each Reporting Person. The percentages used in this Amendment No. 3 are calculated based upon 193,579,119 shares of Common Stock outstanding as of July 17, 2025 as reported in the Prospectus Supplement filed by the Issuer with the SEC on July 21, 2025.
    (b)
    See rows (7) through (10) of the cover pages to this Amendment No. 3 for the number of shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.
    (c)
    Except as described in this Amendment No. 3, the Reporting Persons have not engaged in any transactions in the Common Stock in the past sixty days.
    (d)
    To the knowledge of each of the Reporting Persons, no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock beneficially owned by the Reporting Persons.
    (e)
    N/A
    Item 7.Material to be Filed as Exhibits.
     
    99.1 Joint Filing Agreement dated February 14, 2023 (incorporated by reference to Exhibit 99.1 to Amendment No. 2 to the Schedule 13D filed with the SEC on February 14, 2023) 99.2 Letter Agreement, dated December 1, 2020, by and among the Issuer and its officers, directors and Initial Stockholders (incorporated by reference to Exjbit 10.1 to the Form 8-K filed by the Issuer with the SEC on December 7, 2020) 99.3 Amendment to Letter Agreement, dated July 14, 2021 by and among the Issuer and its officers, directors and Initial Stockholders (incorporated by reference to Exhibit 10.12 to the Form 8-K filed by the Issuer with the SEC on July 19, 2021) 99.4 Amended and Restated Registration Rights Agreement (incorporated by reference to Exhibit 10.10 to the Form 8-K filed by the Issuer with the SEC on July 19, 2021) 99.5 Warrant Agreement (including Form of Warrant), dated July 21, 2025, between the Company, Computershare Inc., a Delaware corporation, and Computershare Trust Company, N.A., as Warrant Agent (incorporated by reference to Exhibit 4.1 to the Form 8-K filed by the Issuer with the SEC on July 21, 2025)

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Thurman J. Rodgers
     
    Signature:/s/Thurman J. Rodgers
    Name/Title:Thurman J. Rodgers
    Date:07/22/2025
     
    Rodgers Massey Revocable Living Trust dtd 4/4/11
     
    Signature:/s/Thurman J. Rodgers
    Name/Title:Thurman J. Rodgers, Trustee
    Date:07/22/2025
     
    Rodgers Family Freedom and Free Markets Charitable Trust
     
    Signature:/s/Thurman J. Rodgers
    Name/Title:Thurman J. Rodgers, Trustee
    Date:07/22/2025
    Get the next $ENVX alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ENVX

    DatePrice TargetRatingAnalyst
    7/24/2025$12.00Overweight → Neutral
    Analyst
    7/8/2025$7.00 → $15.00Hold
    TD Cowen
    10/31/2024Buy → Neutral
    Janney
    7/22/2024$25.00Buy
    The Benchmark Company
    12/18/2023Outperform
    William Blair
    7/21/2023$19.00 → $20.00Outperform → Market Perform
    TD Cowen
    1/11/2023$20.00Buy
    Canaccord Genuity
    12/2/2022$19.00Buy
    B. Riley Securities
    More analyst ratings

    $ENVX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Enovix downgraded by Analyst with a new price target

      Analyst downgraded Enovix from Overweight to Neutral and set a new price target of $12.00

      7/24/25 7:25:56 AM ET
      $ENVX
      Industrial Machinery/Components
      Miscellaneous
    • TD Cowen reiterated coverage on Enovix with a new price target

      TD Cowen reiterated coverage of Enovix with a rating of Hold and set a new price target of $15.00 from $7.00 previously

      7/8/25 8:16:42 AM ET
      $ENVX
      Industrial Machinery/Components
      Miscellaneous
    • Enovix downgraded by Janney

      Janney downgraded Enovix from Buy to Neutral

      10/31/24 9:00:46 AM ET
      $ENVX
      Industrial Machinery/Components
      Miscellaneous

    $ENVX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Legal Officer Chakravarthy Arthi covered exercise/tax liability with 2,217 shares, decreasing direct ownership by 0.51% to 429,117 units (SEC Form 4)

      4 - Enovix Corp (0001828318) (Issuer)

      7/25/25 4:45:42 PM ET
      $ENVX
      Industrial Machinery/Components
      Miscellaneous
    • President and CEO Talluri Rajendra K covered exercise/tax liability with 17,618 shares, decreasing direct ownership by 0.73% to 2,382,253 units (SEC Form 4)

      4 - Enovix Corp (0001828318) (Issuer)

      7/21/25 4:29:02 PM ET
      $ENVX
      Industrial Machinery/Components
      Miscellaneous
    • Chief Operating Officer Marathe Ajay covered exercise/tax liability with 7,338 shares, decreasing direct ownership by 0.63% to 1,165,843 units (SEC Form 4)

      4 - Enovix Corp (0001828318) (Issuer)

      7/15/25 9:08:46 AM ET
      $ENVX
      Industrial Machinery/Components
      Miscellaneous

    $ENVX
    SEC Filings

    See more
    • Enovix Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - Enovix Corp (0001828318) (Filer)

      7/28/25 5:03:00 PM ET
      $ENVX
      Industrial Machinery/Components
      Miscellaneous
    • Amendment: SEC Form SCHEDULE 13D/A filed by Enovix Corporation

      SCHEDULE 13D/A - Enovix Corp (0001828318) (Subject)

      7/22/25 4:41:39 PM ET
      $ENVX
      Industrial Machinery/Components
      Miscellaneous
    • SEC Form CERT filed by Enovix Corporation

      CERT - Enovix Corp (0001828318) (Filer)

      7/21/25 4:33:13 PM ET
      $ENVX
      Industrial Machinery/Components
      Miscellaneous

    $ENVX
    Leadership Updates

    Live Leadership Updates

    See more
    • Enovix Appoints Srikanth Kethu as Head of Enovix India to Accelerate Global Innovation and Regional Expansion

      FREMONT, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (NASDAQ:ENVX) ("Enovix"), a leader in advanced silicon battery technology, today announced the appointment of Srikanth Kethu as Head of Enovix India, effective today. In this key leadership role, Mr. Kethu will oversee the company's Hyderabad R&D center and play a strategic role in supporting the ramp-up of Enovix's high-volume manufacturing facility in Malaysia, while driving the broader expansion of Enovix's footprint in India. Mr. Kethu brings more than two decades of experience leading high-performance engineering teams and scaling offshore operations for global automotive and industrial leaders including ZF, Merc

      7/14/25 8:45:00 AM ET
      $ENVX
      Industrial Machinery/Components
      Miscellaneous
    • Enovix Appoints Ryan Benton as Chief Financial Officer

      FREMONT, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (NASDAQ:ENVX), a global high-performance battery company, announced the appointment of Ryan Benton as Chief Financial Officer (CFO). Mr. Benton brings over three decades of financial leadership experience. He previously held key roles at ASM International and served as CFO for multiple public companies including Silvaco and Exar Corporation. Enovix CEO Dr. Raj Talluri added, "Ryan's experience and transparent communication style make him an ideal leader for our finance organization and a strong voice in conveying our strategy to investors. As we get closer to achieving our top objective of commencing smartphone bat

      4/17/25 8:30:00 AM ET
      $ENVX
      Industrial Machinery/Components
      Miscellaneous
    • Enovix Appoints Kristina Truong as Chief Accounting Officer

      FREMONT, Calif., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Enovix Corporation ("Enovix") (NASDAQ:ENVX), a Silicon Valley high-performance battery manufacturing company, today announced the appointment of Kristina Truong as its first Senior Vice President and Chief Accounting Officer. Kristina will oversee all accounting, controllership and financial reporting, including Sarbanes-Oxley controls. She will also play a key role as part of Enovix's senior leadership team, helping to drive operational excellence and financial transparency as the Company enters its next phase of growth. Enovix CEO Raj Talluri commented, "With Enovix poised for significant growth in 2025 and beyond, and operating in five

      12/30/24 8:30:00 AM ET
      $ENVX
      Industrial Machinery/Components
      Miscellaneous

    $ENVX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Enovix Chairman TJ Rodgers Issues Letter to Shareholders on Warrant Dividend

      FREMONT, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (NASDAQ:ENVX, ENVXW)) ("Company" or "Enovix"), a leader in advanced silicon battery technology, today announced that it distributed a letter from Chairman TJ Rodgers to all shareholders to discuss the Company's recent warrant dividend distribution. A copy of the letter has been posted on the Company's website here. Further Information Relating to the Warrants For more information relating to the exercise mechanics and other terms of the Warrants, please refer to the materials filed by the Company with the Securities and Exchange Commission (the "SEC") available at https://www.sec.gov and the information posted on the C

      7/29/25 8:30:00 AM ET
      $ENVX
      Industrial Machinery/Components
      Miscellaneous
    • Early Warrant Expiration: Preliminary Notice

      Price of Enovix common stock has exceeded $10.50 for five trading days The earliest expiration date for the Warrants is August 19, 2025 Reserves right to set Alternate Expiration Date for Warrants  FREMONT, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (NASDAQ:ENVX, ENVXW)) ("Company" or "Enovix"), a leader in advanced silicon battery technology, today announced that the price of its common stock has exceeded $10.50 for five trading days since the distribution of the warrants to purchase common stock (the "Warrants"), currently traded on Nasdaq under ENVXW. Today's closing price for Enovix common stock was $15.06 per share, and the Warrants are currently in-the-money based

      7/28/25 4:54:28 PM ET
      $ENVX
      Industrial Machinery/Components
      Miscellaneous
    • Enovix Distributes Dividend of Warrants to Stockholders

      FREMONT, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (NASDAQ:ENVX) ("Company" or "Enovix"), a global high-performance battery company, today announced that it will distribute warrants to purchase Enovix common stock ("Warrants") to its shareholders and certain convertible noteholders on Monday, July 21, 2025 (the "Distribution Date"), in accordance with the previously declared shareholder warrant dividend. As previously announced, each stockholder of record as of July 17, 2025 (the "Record Date") will receive one (1) Warrant for every seven (7) shares of Enovix common stock held, rounded down to the nearest whole Warrant. "The distribution of these warrants reflects our c

      7/21/25 8:45:00 AM ET
      $ENVX
      Industrial Machinery/Components
      Miscellaneous

    $ENVX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Enovix Corporation (Amendment)

      SC 13G/A - Enovix Corp (0001828318) (Subject)

      2/14/24 4:05:49 PM ET
      $ENVX
      Industrial Machinery/Components
      Miscellaneous
    • SEC Form SC 13G/A filed by Enovix Corporation (Amendment)

      SC 13G/A - Enovix Corp (0001828318) (Subject)

      2/13/24 5:04:31 PM ET
      $ENVX
      Industrial Machinery/Components
      Miscellaneous
    • SEC Form SC 13G filed by Enovix Corporation

      SC 13G - Enovix Corp (0001828318) (Subject)

      1/29/24 5:25:53 PM ET
      $ENVX
      Industrial Machinery/Components
      Miscellaneous

    $ENVX
    Financials

    Live finance-specific insights

    See more
    • Enovix Chairman TJ Rodgers Issues Letter to Shareholders on Warrant Dividend

      FREMONT, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (NASDAQ:ENVX, ENVXW)) ("Company" or "Enovix"), a leader in advanced silicon battery technology, today announced that it distributed a letter from Chairman TJ Rodgers to all shareholders to discuss the Company's recent warrant dividend distribution. A copy of the letter has been posted on the Company's website here. Further Information Relating to the Warrants For more information relating to the exercise mechanics and other terms of the Warrants, please refer to the materials filed by the Company with the Securities and Exchange Commission (the "SEC") available at https://www.sec.gov and the information posted on the C

      7/29/25 8:30:00 AM ET
      $ENVX
      Industrial Machinery/Components
      Miscellaneous
    • Early Warrant Expiration: Preliminary Notice

      Price of Enovix common stock has exceeded $10.50 for five trading days The earliest expiration date for the Warrants is August 19, 2025 Reserves right to set Alternate Expiration Date for Warrants  FREMONT, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (NASDAQ:ENVX, ENVXW)) ("Company" or "Enovix"), a leader in advanced silicon battery technology, today announced that the price of its common stock has exceeded $10.50 for five trading days since the distribution of the warrants to purchase common stock (the "Warrants"), currently traded on Nasdaq under ENVXW. Today's closing price for Enovix common stock was $15.06 per share, and the Warrants are currently in-the-money based

      7/28/25 4:54:28 PM ET
      $ENVX
      Industrial Machinery/Components
      Miscellaneous
    • Enovix Distributes Dividend of Warrants to Stockholders

      FREMONT, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (NASDAQ:ENVX) ("Company" or "Enovix"), a global high-performance battery company, today announced that it will distribute warrants to purchase Enovix common stock ("Warrants") to its shareholders and certain convertible noteholders on Monday, July 21, 2025 (the "Distribution Date"), in accordance with the previously declared shareholder warrant dividend. As previously announced, each stockholder of record as of July 17, 2025 (the "Record Date") will receive one (1) Warrant for every seven (7) shares of Enovix common stock held, rounded down to the nearest whole Warrant. "The distribution of these warrants reflects our c

      7/21/25 8:45:00 AM ET
      $ENVX
      Industrial Machinery/Components
      Miscellaneous